Clinical Trials Browser

Phase 2 × Terminated × Metastatic Castration-Resistant Prostate Cancer (mCRPC) × Clear all

NCT03712930 2021-11-17

Treatment of Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency

Phase 2 Terminated

13 enrolled 11 charts

Metastatic Castration-Resistant Prostate Cancer (mCRPC)